mlsanityData to 13 Oct 2026

Uplift Modeling based on Graph Neural Network Combined with Causal Knowledge

arXiv 2311.08434 ↗First posted 14 Nov 2023cs.LG cs.AI stat.MLcited by 0

Not on the map. Why?

Abstract (arXiv)

Uplift modeling is a fundamental component of marketing effect modeling, which is commonly employed to evaluate the effects of treatments on outcomes. Through uplift modeling, we can identify the treatment with the greatest benefit. On the other side, we can identify clients who are likely to make favorable decisions in response to a certain treatment. In the past, uplift modeling approaches relied heavily on the difference-in-difference (DID) architecture, paired with a machine learning model as the estimation learner, while neglecting the link and confidential information between features. We proposed a framework based on graph neural networks that combine causal knowledge with an estimate of uplift value. Firstly, we presented a causal representation technique based on CATE (conditional average treatment effect) estimation and adjacency matrix structure learning. Secondly, we suggested a more scalable uplift modeling framework based on graph convolution networks for combining causal knowledge. Our findings demonstrate that this method works effectively for predicting uplift values, with small errors in typical simulated data, and its effectiveness has been verified in actual industry marketing data.

Key facts. No citing papers in the map yet (data through 13 Oct 2026). Builds on 7 of its 22 references that are in the map. First posted on arXiv 14 Nov 2023.

Builds on

7 of 22 references.

References · 7

  1. 2013Domain Generalization via Invariant Feature Representationcited by 623
  2. 2017Causal Effect Inference with Deep Latent-Variable Modelscited by 409
  3. 2017Double/Debiased/Neyman Machine Learning of Treatment Effectscited by 76
  4. 2020CausalML: Python Package for Causal Machine Learningcited by 74
  5. 2016Balancing Covariates via Propensity Score Weightingcited by 65
  6. 2016Approximate Residual Balancing: De-Biased Inference of Average Treatment Effects in High Dimensionscited by 50
  7. 2020Meta Learning for Causal Directioncited by 16

Built on by

Not cited yet.